Sun Pharmaceutical Industries Ltd. closed 10.33% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 11.68% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Sun Pharmaceutical Industries experienced a notable surge in today's session, climbing 2.03% to reach Rs 1786.50. The stock's movement was marked by a significant increase in trading volume ...

ALSO READ: Sensex, Nifty Surge Over 4% in 1 Week: What should investors, traders do? The Nifty 500 and BSE 500 are stock exchanges NSE and BSE's broadest indices, respectively. Top Gainers & Losers: ...

Sun Pharma Advanced Research Company Ltd share price was up by 2.04% from the previous closing price of ₹147.71. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

12 May, 2015 16 Mar, 2016 5:116 244 For every 116 shares held; holder is entitled to apply 5 rights shares at a premium of RS 244 14 Jul, 2011 23 Aug, 2012 1:7 66 For every 7 shares held; holder ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...

Pharmaceutical Refrigerator MED-125 from Kirsch Pharmaceutical Refrigerator MED-85 from Kirsch High Credibility: This website adheres to all nine standards of credibility and transparency.

Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.